HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang-yu Pan Selected Research

Type 2 Diabetes Mellitus (MODY)

11/2013[The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China].
1/2013[The safety and effectiveness of once daily detemir in patients with type 2 diabetes previously failing oral agents: the Chinese cohort from SOLVE(TM) observational study].
12/2012[The baseline characteristics of patients with type 2 diabetes initiating insulin detemir : the Chinese cohort from the SOLVE(TM) study].
1/2007[Effects of intervention therapy of methylcobalamin and folic acid on plasma homocysteine concentration and homocysteine thiolactonases/paraoxonase activity in patients with type 2 diabetes mellitus].
3/2006[Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system].
1/2006[The relationship between metabolic control and the plasma total homocysteine in type 2 diabetes treated with insulin].
7/2004[The efficacy and safety of 30 mg slow-released-gliclazide in type 2 diabetes mellitus].
3/2004[A study comparing the prevalence of urinary albumin excretion and microalbuminuria in pre-diabetes subjects].
10/2002[Study of the gene expression pattern in the Kkay mouse with type 2 diabetes by genomic-scale gene expression analysis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang-yu Pan Research Topics

Disease

9Type 2 Diabetes Mellitus (MODY)
11/2013 - 10/2002
3Body Weight (Weight, Body)
11/2013 - 07/2010
2Hypoglycemia (Reactive Hypoglycemia)
01/2013 - 07/2004
2Insulin Resistance
10/2011 - 10/2008
2Neoplasms (Cancer)
07/2010 - 02/2003
2Glucose Intolerance
03/2006 - 03/2004
1Hyperplasia
12/2013
1Diabetes Complications
12/2012
1Hypokalemia
07/2010
1Alkalosis
07/2010
1Hypertension (High Blood Pressure)
07/2010
1Carcinoid Tumor (Carcinoid)
07/2010
1Edema (Dropsy)
07/2010
1Ectopic ACTH Syndrome
07/2010
1Multiple Endocrine Neoplasia Type 1
01/2009
1Coma (Comas)
01/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
08/2008
1Hyperhomocysteinemia
08/2004
1Diabetic Nephropathies (Diabetic Nephropathy)
08/2004
1Vascular Diseases (Vascular Disease)
03/2004
1Hyperglycemia
03/2004
1Thyroid Neoplasms (Thyroid Cancer)
02/2003
1Graves Disease (Basedow Disease)
02/2003
1Goiter
02/2003
1Thyroid Diseases (Thyroid Disease)
02/2003

Drug/Important Bio-Agent (IBA)

7Glucose (Dextrose)FDA LinkGeneric
11/2013 - 03/2004
3HomocysteineIBA
01/2007 - 08/2004
2Pioglitazone (Actos)FDA Link
11/2013 - 10/2011
2Insulin Detemir (Levemir)FDA Link
01/2013 - 12/2012
2candesartanIBA
07/2010 - 10/2008
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2009 - 07/2004
1alogliptinIBA
11/2013
1Metformin (Glucophage)FDA LinkGeneric
11/2013
1Triglycerides (Triacylglycerol)IBA
10/2011
1Adrenocorticotropic Hormone (ACTH)FDA Link
07/2010
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2010
1Hormones (Hormone)IBA
07/2010
1Hydrocortisone (Cortisol)FDA LinkGeneric
07/2010
1PPAR gammaIBA
10/2008
1mecobalamin (methylcobalamin)IBA
01/2007
1Aryldialkylphosphatase (Paraoxonase)IBA
01/2007
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2007
1Blood Glucose (Blood Sugar)IBA
03/2006
1Insulin (Novolin)FDA Link
01/2006
1Methionine (L-Methionine)FDA Link
08/2004
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2004
1Gliclazide (Diamicron)IBA
07/2004
1AlbuminsIBA
03/2004
1GTP-Binding Proteins (G-Protein)IBA
02/2003
1Gs GTP-Binding Protein alpha Subunits (G(s)alpha)IBA
02/2003
1Messenger RNA (mRNA)IBA
02/2003
1GD 7IBA
02/2003
1Complementary DNA (cDNA)IBA
10/2002

Therapy/Procedure

4Therapeutics
01/2013 - 01/2007
3Glycemic Control
01/2013 - 10/2011
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
12/2013
1Intramuscular Injections
01/2007